These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 10325486)

  • 1. Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne.
    Piérard-Franchimont C; Henry F; Fraiture AL; Fumal I; Piérard GE
    Dermatology; 1999; 198(2):218-22. PubMed ID: 10325486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial.
    Shalita A; Weiss JS; Chalker DK; Ellis CN; Greenspan A; Katz HI; Kantor I; Millikan LE; Swinehart T; Swinyer L; Whitmore C; Baker M; Czernielewski J
    J Am Acad Dermatol; 1996 Mar; 34(3):482-5. PubMed ID: 8609263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris.
    Nyirady J; Grossman RM; Nighland M; Berger RS; Jorizzo JL; Kim YH; Martin AG; Pandya AG; Schulz KK; Strauss JS
    J Dermatolog Treat; 2001 Sep; 12(3):149-57. PubMed ID: 12243706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris.
    Cunliffe WJ; Danby FW; Dunlap F; Gold MH; Gratton D; Greenspan A
    Eur J Dermatol; 2002; 12(4):350-4. PubMed ID: 12095880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris.
    Ellis CN; Millikan LE; Smith EB; Chalker DM; Swinyer LJ; Katz IH; Berger RS; Mills OH; Baker M; Verschoore M; Loesche C
    Br J Dermatol; 1998 Oct; 139 Suppl 52():41-7. PubMed ID: 9990420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of the efficacy and tolerability of 0.1 and 0.03 p.100 adapalene gel and 0.025 p.100 tretinoin gel in the treatment of acne].
    Alirezai M; Meynadier J; Jablonska S; Czernielewski J; Verschoore M
    Ann Dermatol Venereol; 1996; 123(3):165-70. PubMed ID: 8761775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
    Egan N; Loesche MC; Baker MM
    Cutis; 2001 Oct; 68(4 Suppl):20-4. PubMed ID: 11845944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical tretinoin or adapalene in acne vulgaris: an overview.
    Jain S
    J Dermatolog Treat; 2004 Jul; 15(4):200-7. PubMed ID: 15764031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
    Thiboutot D; Gold MH; Jarratt MT; Kang S; Kaplan DL; Millikan L; Wolfe J; Loesche C; Baker M
    Cutis; 2001 Oct; 68(4 Suppl):10-9. PubMed ID: 11845943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adapalene 0.1% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference.
    Dunlap FE; Mills OH; Tuley MR; Baker MD; Plott RT
    Br J Dermatol; 1998 Oct; 139 Suppl 52():17-22. PubMed ID: 9990416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
    Gonzalez P; Vila R; Cirigliano M
    J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of adapalene gel 0.1% vs. tretinoin gel 0.025% in the treatment of acne vulgaris in China.
    Tu P; Li GQ; Zhu XJ; Zheng J; Wong WZ
    J Eur Acad Dermatol Venereol; 2001; 15 Suppl 3():31-6. PubMed ID: 11843231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene.
    Goreshi R; Samrao A; Ehst BD
    J Drugs Dermatol; 2012 Dec; 11(12):1422-6. PubMed ID: 23377511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris.
    Kakita L
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S51-4. PubMed ID: 10898831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials.
    Cunliffe WJ; Poncet M; Loesche C; Verschoore M
    Br J Dermatol; 1998 Oct; 139 Suppl 52():48-56. PubMed ID: 9990421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial.
    Babaeinejad SH; Fouladi RF
    J Drugs Dermatol; 2013 Sep; 12(9):1033-8. PubMed ID: 24002152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial.
    Ioannides D; Rigopoulos D; Katsambas A
    Br J Dermatol; 2002 Sep; 147(3):523-7. PubMed ID: 12207595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irritation potential of tretinoin gel microsphere pump versus adapalene plus benzoyl peroxide gel.
    Leyden JJ; Nighland M; Rossi AB; Ramaswamy R
    J Drugs Dermatol; 2010 Aug; 9(8):998-1003. PubMed ID: 20684151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV).
    Tirado-Sánchez A; Espíndola YS; Ponce-Olivera RM; Bonifaz A
    J Cosmet Dermatol; 2013 Jun; 12(2):103-7. PubMed ID: 23725303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative irritancy comparison of topical retinoid and antimicrobial combination therapies.
    Dosik JS; Gilbert RD; Arsonnaud S
    Skinmed; 2006; 5(5):219-23. PubMed ID: 16957432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.